|FMA||9597 95971, 9597|
The salivary glands in mammals are exocrine glands that produce saliva through a system of ducts. Humans have three paired major salivary glands (parotid, submandibular, and sublingual), as well as hundreds of minor salivary glands. Salivary glands can be classified as serous, mucous, or seromucous (mixed).
In serous secretions, the main type of protein secreted is alpha-amylase, an enzyme that breaks down starch into maltose and glucose, whereas in mucous secretions, the main protein secreted is mucin, which acts as a lubricant.
In humans, 1200 to 1500 ml of saliva are produced every day. The secretion of saliva (salivation) is mediated by parasympathetic stimulation; acetylcholine is the active neurotransmitter and binds to muscarinic receptors in the glands, leading to increased salivation.
The fourth pair of salivary glands, the tubarial glands discovered in 2020, are named for their location, being positioned in front and over the torus tubarius. However, this finding from one study is yet to be confirmed.
The salivary glands are detailed below:
The two parotid glands are major salivary glands wrapped around the mandibular ramus in humans. These are largest of the salivary glands, secreting saliva to facilitate mastication and swallowing, and amylase to begin the digestion of starches. It is the serous type of gland which secretes alpha-amylase (also known as ptyalin). It enters the oral cavity via the parotid duct. The glands are located posterior to the mandibular ramus and anterior to the mastoid process of the temporal bone. They are clinically relevant in dissections of facial nerve branches while exposing the different lobes, since any iatrogenic lesion will result in either loss of action or strength of muscles involved in facial expression. They produce 20% of the total salivary content in the oral cavity. Mumps is a viral infection, caused by infection in the parotid gland.
The submandibular glands (previously known as submaxillary glands) are a pair of major salivary glands located beneath the lower jaws, superior to the digastric muscles. The secretion produced is a mixture of both serous fluid and mucus, and enters the oral cavity via the submandibular duct or Wharton duct. Around 70% of saliva in the oral cavity is produced by the submandibular glands, though they are much smaller than the parotid glands. This gland can usually be felt via palpation of the neck, as it is in the superficial cervical region and feels like a rounded ball. It is located about two fingers above the Adam's apple (laryngeal prominence) and about two inches apart under the chin.
The sublingual glands are a pair of major salivary glands located inferior to the tongue, anterior to the submandibular glands. The secretion produced is mainly mucous in nature, but it is categorized as a mixed gland. Unlike the other two major glands, the ductal system of the sublingual glands does not have intercalated ducts and usually does not have striated ducts, either, so saliva exits directly from 8-20 excretory ducts known as the Rivinus ducts. About 5% of saliva entering the oral cavity comes from these glands.
Tubarial salivary glands
This section needs expansion. You can help by adding to it. (October 2020)
The tubarial glands are suggested as a fourth pair of salivary glands situated posteriorly in the nasopharynx and nasal cavity, predominantly with mucous glands, and its ducts opening into the dorsolateral pharyngeal wall. The glands were unknown until September 2020, when they were discovered by a group of Dutch scientists using with prostate-specific membrane antigen PET-CT. This discovery may explain mouth dryness after radiotherapy despite the avoidance of the three major glands. However, these findings from just one study need to be confirmed. On the other hand, an interdisciplinary group of scientists disagree with this new discovery. They believe that an accumulation of minor salivary glands has been described.
Minor salivary glands
Around 800 to 1,000 minor salivary glands are located throughout the oral cavity within the submucosa of the oral mucosa in the tissue of the buccal, labial, and lingual mucosa, the soft palate, the lateral parts of the hard palate, and the floor of the mouth or between muscle fibers of the tongue. They are 1 to 2 mm in diameter and unlike the major glands, they are not encapsulated by connective tissue, only surrounded by it. The gland has usually a number of acini connected in a tiny lobule. A minor salivary gland may have a common excretory duct with another gland, or may have its own excretory duct. Their secretion is mainly mucous in nature and have many functions such as coating the oral cavity with saliva. Problems with dentures are sometimes associated with minor salivary glands if dry mouth is present. The minor salivary glands are innervated by the seventh cranial or facial nerve.
Von Ebner's glands
Von Ebner's glands are found in a trough circling the circumvallate papillae on the dorsal surface of the tongue near the terminal sulcus. They secrete a purely serous fluid that begins lipid hydrolysis. They also facilitate the perception of taste through secretion of digestive enzymes and proteins. The arrangement of these glands around the circumvallate papillae provides a continuous flow of fluid over the great number of taste buds lining the sides of the papillae, and is important for dissolving the food particles to be tasted.
Salivary glands are innervated, either directly or indirectly, by the parasympathetic and sympathetic arms of the autonomic nervous system. Parasympathetic stimulation evokes a copious flow of saliva.
- Parasympathetic innervation to the salivary glands is carried via cranial nerves. The parotid gland receives its parasympathetic input from the glossopharyngeal nerve (CN IX) via the otic ganglion, while the submandibular and sublingual glands receive their parasympathetic input from the facial nerve (CN VII) via the submandibular ganglion. These nerves release acetylcholine and substance P, which activate the IP3 and DAG pathways respectively.
- Direct sympathetic innervation of the salivary glands takes place via preganglionic nerves in the thoracic segments T1-T3 which synapse in the superior cervical ganglion with postganglionic neurons that release norepinephrine, which is then received by β1-adrenergic receptors on the acinar and ductal cells of the salivary glands, leading to an increase in cyclic adenosine monophosphate (cAMP) levels and the corresponding increase of saliva secretion. Note that in this regard both parasympathetic and sympathetic stimuli result in an increase in salivary gland secretions, the difference lies on the composition of this saliva, once sympathetic stimulus results particularly in the increase of amilase secretion, which is produced by serous glands. The sympathetic nervous system also affects salivary gland secretions indirectly by innervating the blood vessels that supply the glands, resulting in vasoconstriction through the activation of α1 adrenergic receptors, lessening the saliva's water content.
Secretory cells are found in a group, or acinus. Each acinus is located at the terminal part of the gland connected to the ductal system, with many acini within each lobule of the gland. Each acinus consists of a single layer of cuboidal epithelial cells surrounding a lumen, a central opening where the saliva is deposited after being produced by the secretory cells. The three forms of acini are classified in terms of the type of epithelial cell present and the secretory product being produced - serous, mucoserous, and mucous.
In the duct system, the lumina are formed by intercalated ducts, which in turn join to form striated ducts. These drain into ducts situated between the lobes of the gland (called interlobar ducts or secretory ducts). These are found on most major and minor glands (exception may be the sublingual gland).
All of the human salivary glands terminate in the mouth, where the saliva proceeds to aid in digestion. The released saliva is quickly inactivated in the stomach by the acid that is present, but saliva also contains enzymes that are actually activated by stomach acid.
Gene and protein expression
About 20,000 protein-coding genes are expressed in human cells and 60% of these genes are expressed in normal, adult salivary glands. Less than 100 genes are more specifically expressed in the salivary gland. The salivary gland specific genes are mainly genes that encode for secreted proteins and compared to other organs in the human body; the salivary gland has the highest fraction of secreted genes. The heterogeneous family of proline-rich, human salivary glycoproteins, such as PRB1 and PRH1, are salivary gland-specific proteins with highest level of expression. Examples of other specifically expressed proteins include the digestive amylase enzyme AMY1A, the mucin MUC7 and statherin, all of major importance for specific characteristics of saliva.
- Decrease in volume of acinar tissue
- Increase in fibrous tissue
- Increase in adipose tissue
- Ductal hyperplasia and dilation
In addition, changes occur in salivary contents:
- Decrease in concentration of secretory IgE 
- Decrease in the amount of mucin
However, no overall change in the amount of saliva secreted is seen.
This section needs expansion. You can help by adding to it. (January 2018)
Salivary glands secrete saliva, which has many benefits for the oral cavity and health in general. The knowledge of normal salivary flow rate (SFR) is extremely important when treating dental patients. These benefits include:
- Protection: Saliva consists of proteins (for example; mucins) that lubricate and protect both the soft and hard tissues of the oral cavity. Mucins are the principal organic constituents of mucus, the slimy viscoelastic material that coats all mucosal surfaces.
- Buffering: In general, the higher the saliva flow rate, the faster the clearance and the higher the buffer capacity, hence better protection from dental caries. Therefore, people with a slower rate of saliva secretion, combined with a low buffer capacity, have lessened salivary protection against microbes.
- Pellicle formation: Saliva forms a pellicle on the surface of the tooth to prevent wearing. The film contains mucins and proline-rich glycoprotein from the saliva.
The proteins (statherin and proline-rich proteins) within the salivary pellicle inhibit demineralisation and promote remineralisation by attracting calcium ions.
- Maintenance of tooth integrity: Demineralization occurs when enamel disintegrates due to the presence of acid. When this occurs, the buffering capacity effect of saliva (increases saliva flow rate) inhibits demineralisation. Saliva can then begin to promote the remineralisation of the tooth by strengthening the enamel with calcium and phosphate minerals.
- Antimicrobial action: Saliva can prevent microbial growth based on the elements it contains. For example, lactoferrin in saliva binds naturally with iron. Since iron is a major component of bacterial cell walls, removal of iron breaks down the cell wall, which in turn breaks down the bacterium. Antimicrobial peptides such as histatins inhibit the growth of Candida albicans and Streptococcus mutans. Salivary immunoglobulin A serves to aggregate oral bacteria such as S. mutans and prevent the formation of dental plaque.
- Tissue repair: Saliva can encourage soft-tissue repair by decreasing clotting time and increasing wound contraction.
- Digestion: Saliva contains amylase, which hydrolyses starch into glucose, maltose, and dextrin. As a result, saliva allows some digestion to occur before the food reaches the stomach.
- Taste: Saliva acts as a solvent in which solid particles can dissolve and enter the taste buds through oral mucosa located on the tongue. These taste buds are found within foliate and circumvallate papillae, where minor salivary glands secrete saliva.
Salivary gland dysfunction refers to either xerostomia (the symptom of dry mouth) or salivary gland hypofunction (reduced production of saliva); it is associated with significant impairment of quality of life. Following radiotherapy of the head and neck region, salivary gland dysfunction is a predictable side-effect. Saliva production may be pharmacologically stimulated by sialagogues such as pilocarpine and cevimeline. It can also be suppressed by so-called antisialagogues such as tricyclic antidepressants, SSRIs, antihypertensives, and polypharmacy. A Cochrane review found there was no strong evidence that topical therapies are effective in relieving the symptoms of dry mouth.
Cancer treatments including chemotherapy and radiation therapy may impair salivary flow. Radiotherapy can cause permanent hyposalivation due to injury to the oral mucosa containing the salivary glands, resulting in xerostomia, whereas chemotherapy may cause only temporary salivary impairment. Furthermore surgical removal because of benign or malignant lesions may also impair function.
Graft versus host disease after allogeneic bone marrow transplantation may manifest as dry mouth and many small mucoceles. Salivary gland tumours may occur, including mucoepidermoid carcinoma, a malignant growth.
The salivary glands of some species are modified to produce proteins; salivary amylase is found in many bird and mammal species (including humans, as noted above). Furthermore, the venom glands of venomous snakes, Gila monsters, and some shrews, are actually modified salivary glands. In other organisms such as insects, salivary glands are often used to produce biologically important proteins such as silk or glues, whilst fly salivary glands contain polytene chromosomes that have been useful in genetic research.
- Edgar, Michael; Dawes, Colin; O'Mullane, Denis, eds. (2012). Saliva and oral health (4th ed.). Stephen Hancocks. p. 1. ISBN 978-0-9565668-3-6.
- Martini, Frederic H.; Nath, Judi L.; Bartholomew, Edwin (2012). Fundamentals of anatomy & physiology (9th ed.). Pearson Benjamin Cummings. ISBN 9780321709332.
- James, Eleanor; Ellis, Cathy; Brassington, Ruth; Sathasivam, Sivakumar; Young, Carolyn A. (2022-05-20). "Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis". The Cochrane Database of Systematic Reviews. 5: CD006981. doi:10.1002/14651858.CD006981.pub3. ISSN 1469-493X. PMC 9121913. PMID 35593746.
- Davies, Andrew N; Thompson, Jo (2015-10-05). "Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy". Cochrane Database of Systematic Reviews (10): CD003782. doi:10.1002/14651858.CD003782.pub3. PMC 6599847. PMID 26436597.
- Wu, Katherine J. (2020-10-19). "Doctors May Have Found Secretive New Organs in the Center of Your Head". The New York Times. Retrieved 2020-10-22.
- Bialek EJ, Jakubowski W, Zajkowski P, Szopinski KT, Osmolski A (2006). "US of the major salivary glands: anatomy and spatial relationships, pathologic conditions, and pitfalls". Radiographics. 26 (3): 745–63. doi:10.1148/rg.263055024. PMID 16702452.
- Nanci A (2018). Ten Cate's Oral Histology: Development, Structure, and Function (ninth ed.). ISBN 978-0-323-48524-1.
- Holmberg KV, Hoffman MP (2014). "Anatomy, biogenesis and regeneration of salivary glands". Saliva: Secretion and Functions. Monographs in Oral Science. Vol. 24. pp. 1–13. doi:10.1159/000358776. ISBN 978-3-318-02595-8. PMC 4048853. PMID 24862590.
- Hviid A, Rubin S, Mühlemann K (2008). "Mumps". Lancet. 371 (9616): 932–44. doi:10.1016/S0140-6736(08)60419-5. PMID 18342688. S2CID 208793825.
- Valstar, Matthijs H.; de Bakker, Bernadette S.; Steenbakkers, Roel J. H. M.; de Jong, Kees H.; Smit, Laura A.; Klein Nulent, Thomas J. W.; van Es, Robert J. J.; Hofland, Ingrid; de Keizer, Bart; Jasperse, Bas; Balm, Alfons J. M.; van der Schaaf, Arjen; Langendijk, Johannes A.; Smeele, Ludi E.; Vogel, Wouter V. (2020-09-22). "The tubarial salivary glands: A potential new organ at risk for radiotherapy". Radiotherapy and Oncology. 154: 292–298. doi:10.1016/j.radonc.2020.09.034. PMID 32976871.
- Guntinas-Lichius, Orlando; Ihrler, Stephan; Freesmeyer, Martin; Gühne, Falk; Kluge, Regine; Bräuer, Lars; Iro, Heinrich; Paulsen, Friedrich; Dietz, Andreas; Bechmann, Ingo (2020-11-16). "Gibt es eine neue Kopfspeicheldrüse? – Eher nicht!". Laryngo-Rhino-Otologie (in German). 100 (1): a–1307–3872. doi:10.1055/a-1307-3872. ISSN 0935-8943. PMID 33197955.
- Nanci A (2013). Ten Cate's Oral Histology: Development, Structure, and Function (8th ed.). Elsevier. pp. 275–65. ISBN 978-0-323-07846-7.
- Herring MJ, Fehrenbach SW (2012). Illustrated Anatomy of the Head and Neck (4th ed.). Elsevier/Saunders. ISBN 978-1-4377-2419-6.
- Frommer J (1977). "The human accessory parotid gland: its incidence, nature, and significance". Oral Surgery, Oral Medicine, and Oral Pathology. 43 (5): 671–6. doi:10.1016/0030-4220(77)90049-4. PMID 266146.
- Ishizuka K, Oskutyte D, Satoh Y, Murakami T (2010). "Multi-source inputs converge on the superior salivatory nucleus neurons in anaesthetized rats". Autonomic Neuroscience: Basic & Clinical. 156 (1–2): 104–10. doi:10.1016/j.autneu.2010.03.014. PMID 20435522. S2CID 25907120.
- Costanzo L (2009). Physiology (3rd ed.). Saunders Elsevier. ISBN 978-1-4160-2320-3.
- Bath-Balogh M, Fehrenbach M (2011). Illustrated Dental Embryology, Histology, and Anatomy. Elsevier. p. 132. ISBN 978-1-4377-2934-4.
- Gilloteaux, J.; Afolayan, A. (2014). "Clarification of the terminology of the major human salivary glands: Acinus and alveolus are not synonyms". The Anatomical Record. 297 (8): 1354–63. doi:10.1002/ar.22950. PMID 24903594.
- "The human proteome in salivary gland - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2017-09-22.
- Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. (January 2015). "Proteomics. Tissue-based map of the human proteome". Science. 347 (6220): 1260419. doi:10.1126/science.1260419. PMID 25613900. S2CID 802377.
- Vissink A, Spijkervet FK, Van Nieuw Amerongen A (1996). "Aging and saliva: a review of the literature". Special Care in Dentistry. 16 (3): 95–103. doi:10.1111/j.1754-4505.1996.tb00842.x. PMID 9084322.
- Kim SK, Allen ED (June 1994). "Structural and functional changes in salivary glands during aging". Microscopy Research and Technique. 28 (3): 243–53. doi:10.1002/jemt.1070280308. PMID 8068986. S2CID 12964266.
- Sawair, Faleh A (2009). "The Unstimulated Salivary Flow Rate in a Jordanian Healthy Adult Population". Journal of Clinical Medicine Research. doi:10.4021/jocmr2009.10.1267. PMC 3299184. PMID 22461872.
- Tabak LA, Levine MJ, Mandel ID, Ellison SA (February 1982). "Role of salivary mucins in the protection of the oral cavity". Journal of Oral Pathology and Medicine. 11 (1): 1–17. doi:10.1111/j.1600-0714.1982.tb00138.x. PMID 6801238.
- Comba, Allegra. "Saliva". flipper e nuvola. Retrieved 25 February 2018.
- "Function of Saliva". Cariology. Retrieved 24 February 2018.
- "6 Ways Saliva Protects Your Teeth". Sunningdale Dental News & Views. 2012-07-17. Retrieved 25 February 2018.
- Taylor, John. "Immunity in the oral cavity". British Society for Immunology. Retrieved 25 February 2018.
- Mandel, ID (February 1987). "The functions of saliva". Journal of Dental Research. 66 Spec No (66): 623–7. doi:10.1177/00220345870660S203. PMID 3497964. S2CID 23498530.
- "Saliva". Science Daily. Retrieved 24 February 2018.
- Nanci A (2003). Ten Cate's oral histology: development, structure, and function (6th ed.). Mosby. pp. 300–1. ISBN 978-0-323-01614-8.
- Matsuo, R (2000). "Role of Saliva in the maintenance of taste sensitivity". Critical Reviews in Oral Biology and Medicine. 11 (2): 216–29. doi:10.1177/10454411000110020501. PMID 12002816.
- Rzymska-Grala I, Stopa Z, Grala B, Gołębiowski M, Wanyura H, Zuchowska A, Sawicka M, Zmorzyński M (July 2010). "Salivary gland calculi - contemporary methods of imaging". Polish Journal of Radiology. 75 (3): 25–37. PMC 3389885. PMID 22802788.
- Riley, Philip; Glenny, Anne-Marie; Hua, Fang; Worthington, Helen V (2017-07-31). "Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy". Cochrane Database of Systematic Reviews. 7: CD012744. doi:10.1002/14651858.CD012744. PMC 6483146. PMID 28759701.
- Wolff A, Joshi RK, Ekström J, Aframian D, Pedersen AM, Proctor G, Narayana N, Villa A, Sia YW, Aliko A, McGowan R, Kerr AR, Jensen SB, Vissink A, Dawes C (March 2017). "A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI". Drugs in R&D. 17 (1): 1–28. doi:10.1007/s40268-016-0153-9. PMC 5318321. PMID 27853957.
- Romer AS, Parsons TS (1977). The Vertebrate Body. Holt-Saunders International. pp. 299–300. ISBN 978-0-03-910284-5.
- Furness, Susan; Worthington, Helen; Bryan, Gemma; Birchenough, Sarah; McMillan, Roddy (7 December 2011). "Interventions for the management of dry mouth: topical therapies". Cochrane Database of Systematic Reviews (12): CD008934. doi:10.1002/14651858.CD008934.pub2. PMID 22161442.
- Psychogios, Georgios; Bohr, Christopher; Constantinidis, Jannis; Canis, Martin; Vander Poorten, Vincent; Plzak, Jan; Knopf, Andreas; Betz, Christian; Guntinas-Lichius, Orlando; Zenk, Johannes (2020-08-04). "Review of surgical techniques and guide for decision making in the treatment of benign parotid tumors". European Archives of Oto-Rhino-Laryngology. 278 (1): 15–29. doi:10.1007/s00405-020-06250-x. ISSN 0937-4477. PMID 32749609. S2CID 220965351.
- Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, Yoshino M, Ono M, Yang HY, Mashima Y, Oguchi Y, Ikeda Y, Tsubota K (October 1999). "Dry eye after haematopoietic stem cell transplantation". The British Journal of Ophthalmology. 83 (10): 1125–30. doi:10.1136/bjo.83.10.1125. PMC 1722843. PMID 10502571.
- Nance MA, Seethala RR, Wang Y, Chiosea SI, Myers EN, Johnson JT, Lai SY (October 2008). "Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma". Cancer. 113 (8): 2082–9. doi:10.1002/cncr.23825. PMC 2746751. PMID 18720358.
- Rastogi R, Bhargava S, Mallarajapatna GJ, Singh SK (October 2012). "Pictorial essay: Salivary gland imaging". The Indian Journal of Radiology & Imaging. 22 (4): 325–33. doi:10.4103/0971-3026.111487. PMC 3698896. PMID 23833425.
- Sehnal F, Sutherland T (2008). "Silks produced by insect labial glands". Prion. 2 (4): 145–53. doi:10.4161/pri.2.4.7489. PMC 2658764. PMID 19221523.